National

European Parliament dismayed at US policy towards Russia

Apr 03, 2025

Moscow [Russia], April 3: Members of the European Parliament have expressed dismay at the new US administration's policy on Russia.
A clear majority supports parliamentary reports criticizing appeasement towards Russia, the European Parliament said in a statement on Wednesday. "MEPs are worried about the fast pace at which the new US administration is reversing established partnerships and dismayed by its policy of appeasing Russia and targeting traditional allies," the statement said.
Around two-thirds of the members present in Strasbourg for the vote voted in favour of reports on EU foreign and defence policy. It was also stated that the members of parliament "strongly deplore any attempts at blackmailing Ukraine's leadership into surrendering to the Russian aggressor for the sole purpose of announcing a 'peace deal.'" However, they also emphasized that it is more important than ever to continue to work with the United States.
Source: Qatar Tribune

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025